Annual FCF:
-$207.34M-$70.03M(-51.01%)Summary
- As of today, KYMR annual free cash flow is -$207.34 million, with the most recent change of -$70.03 million (-51.01%) on December 31, 2024.
- During the last 3 years, KYMR annual free cash flow has fallen by -$76.80 million (-58.83%).
- KYMR annual free cash flow is now -362.34% below its all-time high of $79.03 million, reached on December 31, 2020.
Performance
KYMR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly FCF:
-$27.29M+$33.29M(+54.95%)Summary
- As of today, KYMR quarterly free cash flow is -$27.29 million, with the most recent change of +$33.29 million (+54.95%) on September 30, 2025.
- Over the past year, KYMR quarterly free cash flow has increased by +$22.71 million (+45.42%).
- KYMR quarterly free cash flow is now -121.11% below its all-time high of $129.26 million, reached on September 30, 2020.
Performance
KYMR Quarterly Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$230.21M+$22.71M(+8.98%)Summary
- As of today, KYMR TTM free cash flow is -$230.21 million, with the most recent change of +$22.71 million (+8.98%) on September 30, 2025.
- Over the past year, KYMR TTM free cash flow has dropped by -$82.01 million (-55.34%).
- KYMR TTM free cash flow is now -357.10% below its all-time high of $89.54 million, reached on September 30, 2020.
Performance
KYMR TTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
KYMR Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -51.0% | +45.4% | -55.3% |
| 3Y3 Years | -58.8% | +23.2% | -48.6% |
| 5Y5 Years | -1293.5% | -121.1% | -357.1% |
KYMR Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -58.8% | at low | -662.3% | +65.7% | -68.9% | +9.0% |
| 5Y | 5-Year | -362.3% | at low | -121.1% | +65.7% | -357.1% | +9.0% |
| All-Time | All-Time | -362.3% | at low | -121.1% | +65.7% | -357.1% | +9.0% |
KYMR Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$27.29M(+54.9%) | -$230.21M(+9.0%) |
| Jun 2025 | - | -$60.58M(+23.9%) | -$252.92M(-5.4%) |
| Mar 2025 | - | -$79.62M(-26.9%) | -$239.96M(-15.7%) |
| Dec 2024 | -$207.34M(-51.0%) | -$62.72M(-25.4%) | -$207.34M(-39.9%) |
| Sep 2024 | - | -$50.00M(-5.0%) | -$148.20M(-7.5%) |
| Jun 2024 | - | -$47.63M(-1.3%) | -$137.92M(-1.2%) |
| Mar 2024 | - | -$46.99M(-1212.7%) | -$136.32M(+0.7%) |
| Dec 2023 | -$137.31M(+11.9%) | -$3.58M(+91.0%) | -$137.31M(+20.9%) |
| Sep 2023 | - | -$39.73M(+13.7%) | -$173.63M(-2.5%) |
| Jun 2023 | - | -$46.02M(+4.1%) | -$169.43M(-3.9%) |
| Mar 2023 | - | -$47.98M(-20.2%) | -$163.12M(-4.6%) |
| Dec 2022 | -$155.92M | -$39.91M(-12.4%) | -$155.92M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$35.52M(+10.6%) | -$154.87M(+1.3%) |
| Jun 2022 | - | -$39.72M(+2.6%) | -$156.92M(-5.8%) |
| Mar 2022 | - | -$40.78M(-5.0%) | -$148.33M(-13.6%) |
| Dec 2021 | -$130.54M(-265.2%) | -$38.85M(-3.4%) | -$130.54M(-15.3%) |
| Sep 2021 | - | -$37.57M(-20.6%) | -$113.19M(-311.1%) |
| Jun 2021 | - | -$31.14M(-35.5%) | $53.63M(-22.8%) |
| Mar 2021 | - | -$22.99M(-6.9%) | $69.50M(-12.1%) |
| Dec 2020 | $79.03M(+354.9%) | -$21.50M(-116.6%) | $79.03M(-11.7%) |
| Sep 2020 | - | $129.26M(+946.6%) | $89.54M(+325.4%) |
| Jun 2020 | - | -$15.27M(-13.5%) | -$39.72M(-62.4%) |
| Mar 2020 | - | -$13.45M(-22.3%) | -$24.45M(-122.3%) |
| Dec 2019 | $17.37M(+190.4%) | -$11.00M | -$11.00M |
| Dec 2018 | -$19.22M | - | - |
FAQ
- What is Kymera Therapeutics, Inc. annual free cash flow?
- What is the all-time high annual free cash flow for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. annual free cash flow year-on-year change?
- What is Kymera Therapeutics, Inc. quarterly free cash flow?
- What is the all-time high quarterly free cash flow for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. quarterly free cash flow year-on-year change?
- What is Kymera Therapeutics, Inc. TTM free cash flow?
- What is the all-time high TTM free cash flow for Kymera Therapeutics, Inc.?
- What is Kymera Therapeutics, Inc. TTM free cash flow year-on-year change?
What is Kymera Therapeutics, Inc. annual free cash flow?
The current annual free cash flow of KYMR is -$207.34M
What is the all-time high annual free cash flow for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high annual free cash flow is $79.03M
What is Kymera Therapeutics, Inc. annual free cash flow year-on-year change?
Over the past year, KYMR annual free cash flow has changed by -$70.03M (-51.01%)
What is Kymera Therapeutics, Inc. quarterly free cash flow?
The current quarterly free cash flow of KYMR is -$27.29M
What is the all-time high quarterly free cash flow for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high quarterly free cash flow is $129.26M
What is Kymera Therapeutics, Inc. quarterly free cash flow year-on-year change?
Over the past year, KYMR quarterly free cash flow has changed by +$22.71M (+45.42%)
What is Kymera Therapeutics, Inc. TTM free cash flow?
The current TTM free cash flow of KYMR is -$230.21M
What is the all-time high TTM free cash flow for Kymera Therapeutics, Inc.?
Kymera Therapeutics, Inc. all-time high TTM free cash flow is $89.54M
What is Kymera Therapeutics, Inc. TTM free cash flow year-on-year change?
Over the past year, KYMR TTM free cash flow has changed by -$82.01M (-55.34%)